(Q40209531)

18 September 2017

title

Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression (English)

1 reference

18 September 2017

1 reference

cervix uterine cancer

1 reference

Bharathi Ramdass

1

1 reference

18 September 2017

Tessy T Maliekal

2

1 reference

18 September 2017

S Lakshmi

3

1 reference

18 September 2017

Michael Rehman

4

1 reference

18 September 2017

P Rema

5

1 reference

18 September 2017

Pradip Nair

6

1 reference

18 September 2017

Geetashree Mukherjee

7

1 reference

18 September 2017

B K M Reddy

8

1 reference

18 September 2017

Sudhir Krishna

9

1 reference

18 September 2017

M Radhakrishna Pillai

10

1 reference

18 September 2017

language of work or name

English

0 references

publication date

13 November 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

104

1 reference

18 September 2017

issue

2

1 reference

18 September 2017

page(s)

352-361

1 reference

Alterations in Notch signaling in neoplastic lesions of the human cervix

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Changes in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Notch signaling: cell fate control and signal integration in development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Activated Notch1 signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB/Akt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

c-Myc substitutes for Notch1-CBF1 functions in cooperative transformation with papillomavirus oncogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Constitutive activation of nuclear factor -kB: preferntial homodimerization of p50 subunits in cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

NF-kappaB in cancer: from innocent bystander to major culprit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

7 January 2021

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Nuclear factor-kappa B and cancer: its role in prevention and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Notch1 augments NF-kappaB activity by facilitating its nuclear retention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Decreased programmed cell death in the uterine cervix associated with high risk human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Activation of AKT/PKB in breast cancer predicts a worse outcome among endocrine treated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

AKT activation predicts outcome in breast cancer patients treated with tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

The clinical significance between activation of nuclear factor kappa B transcription factor and overexpression of HER-2/neu oncoprotein in Taiwanese patients with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Minireview: Cyclin D1: normal and abnormal functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Role of NF-κB in p53-mediated programmed cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

P53 expression as a predictor of recurrence in cervical squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Expression pattern of the AP-1 family in endometrial cancer: correlations with cell cycle regulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

c-fos overexpression is associated with the pathoneogenesis of invasive cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.054

10.1016/J.YGYNO.2006.08.054

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference